PapersTrialsTopicsCompoundsCountriesStakeholdersPeopleCoursesEvents
Browse all papers

Latest papers

Long-term efficacy of psilocybin with adjunct psychotherapy in treatment-resistant depressionPsilocybin · Treatment-resistant depressionDrug-drug interactions between psychiatric medications and MDMA or psilocybinMDMA & psilocybin · SafetyAn international mega-analysis of psychedelic drug effects on brain circuit functionCross-compound · NeuroimagingEsketamine in treatment-resistant depression with and without comorbid borderline personalityEsketamine · Treatment-resistant depression

Featured

Road to Access

Science, regulation, and economics on the path to patient access.

01Evidence02Approval03Reimbursement04Delivery05Access—Big Picture
Start the journey
ResultsCompare outcome data across trials and publications.Research SnapshotOne-page overview of trials, participants, papers, and research networks.Clinical GuidelinesTrial-anchored manuals and protocol guidance with competency mapping.Research recapsMonthly evidence summaries with key takeaways.Map of researchLandscape view of trials, compounds, and outcomes.NewsletterWeekly or daily updates on trials, publications, analysis, and more.Research GroupsWorldwide map of psychedelic research centres by region.Research NetworkInteractive co-authorship map of psychedelic researchers.Top papersFind needles in the haystack of psychedelic research per topic.
AskBeta
Pricing
Back to journals
Academic Journal

Clinical Hemorheology and Microcirculation

1 Papers Indexed in Blossom

Data updated June 16, 2026

Research Footprint

Clinical Hemorheology and Microcirculation has 1 tracked paper indexed in Blossom (2018) from 11 authors, most often covering DMT, across Immunology & Inflammation.

Published Papers

Paywallindividual

Hemorheological and metabolic consequences of renal ischemia-reperfusion and their modulation by N,N-dimethyl-tryptamine on a rat model

Renal ischaemia–reperfusion in rats causes metabolic disturbance (raised lactate, acidosis) and adverse micro-rheological changes (increased erythrocyte aggregation, reduced deformability). Pre‑treatment with the sigma‑1 receptor agonist N,N‑dimethyltryptamine attenuated but did not fully prevent these metabolic and micro‑rheological alterations.

Published
April 13, 2018
Journal
Clinical Hemorheology and Microcirculation
Authors
Peto, K., Nemeth, N., Mester, A., Magyar, Z., Ghanem, S., Somogyi, V., Tanczos, B., Deak, A., Bidiga, L., Frecska, E., Nemes, B.

Quick Facts

Papers Indexed
1
h-Index
64
Open Access
No
Publisher
SAGE Publications
Country
Netherlands
Website
Visit

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners
  • Clinical Guidelines

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.